Caribou Biosciences

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

Caribou Biosciences Inc

News

Legal

Press Releases

CARIBOU ALERT: Bragar Eagel & Squire, P.C. is Investigating Caribou Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

Earnings

Caribou Biosciences Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

Caribou Biosciences to Participate in the BofA Securities 2025 Health Care Conference

Caribou Biosciences Reports First Quarter 2025 Financial Results and Provides Business Update

Health Care

Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference

Biotech's Turning Point: 4 Stocks Poised to Ride the 2025 Wave (MDCX, ACTU, CRBU, NMRA)

Biotech's Turning Point: 4 Stocks Poised to Ride the 2025 Wave

Caribou Biosciences Reports Second Quarter 2025 Financial Results and Provides Business Update

ACTU

CRBU

MDCX

NMRA

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

C4 Therapeutics

Climb Bio

Cardiff Oncology

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals

Elicio Therapeutics

Enanta Pharmaceuticals, Inc. - Common Stock

Enanta Pharma

Eupraxia Pharmaceuticals Inc. - Common Stock

Eupraxia Pharmaceuticals

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Immuneering Corporation - Class A Common Stock

Immuneering

Ironwood Pharmaceuticals, Inc. - Class A Common Stock

Ironwood Pharmaceuticals

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Seres Therapeutics

MEI Pharma

Nkarta

Nuvectis Pharma

RAPT Therapeutics

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Theratechnologies

Instil Bio

Tenaya Therapeutics

Tevogen Bio Holdings

Voyager Therapeutics, Inc. - Common Stock

Comments

Caribou Biosciences

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL